Number of Shares
3.29 Mil
Current Holdings Value*
$228.39 Mil
% of Portfolio
1.63%
Total Estimate Gain
$275.08 Mil
% of Total Estimate Gain
79.95%

Loomis Sayles Growth Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, LOOMIS SAYLES FUNDS II held 3.29 Mil shares of Novo Nordisk AS(NVO), totaling $228.39 Mil. This investment constitutes 1.63% of their stock portfolio, and LOOMIS SAYLES FUNDS II now holds 0.07% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2019Q3. And since then Loomis Sayles Growth Fund has made 6 purchases of NVO, at an average price of $32.82, for a total of 10.48 Mil shares. In addition, there have been 7 sales at an average price of $55.53 for 7.19 Mil shares. Based on historical transaction data and NVO's current price of $66.78, Loomis Sayles Growth Fund's estimated gain on his NVO holdings is $275.08 Mil, reflecting a 79.95% gain to date.

Loomis Sayles Growth Fund NVO ($66.78) Holding Chart

Loomis Sayles Growth Fund NVO ($66.78) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1